Section: 
School of pharmacotherapy
School of pharmacotherapyClinical efficacy of the drug 200 mg silver proteinate in the complex therapy of acute infectious rhinitis in children, which occurred as part of an acute respiratory infection
A. B. Kiselev (1), Kh. T. Abdulkerimov (2), N. E. Terskova (3), V. A. Chaukina (1)
(1) Novosibirsk State Medical University, Novosibirsk, 630091, Russia, (2) Ural State Medical University, Yekaterinburg, 620028, Russia, (3) Voino-Yasenetskii Krasnoyarsk State Medical University, Krasnoyarsk, 660022, Russia
UDK: 616.211.1 -08.-039.73:615.28
DOI: https://doi.org/10.18692/1810-4800-2021-4-88-95
ABSTRACT
The effectiveness of pharmacotherapy of acute infectious rhinitis in children by means of drugs from the list of medicines of the J00 Standard and in addition to this pharmacotherapy with the drug silver proteinate – 200 mg nasal spray Sialor® (manufacturer of JSC «Production Pharmaceutical Company “Obnovlenie”, Russia) was evaluated in a multicenter randomized comparative study. A higher quality of treatment was demonstrated when using 200 mg silver proteinate (Sialor®) in the form of a nasal spray in complex therapy. The article presents evidence of the feasibility of including the drug 200 mg silver proteinate in the list of medicines of the J00 Standard.
Publication date:
07.08.2021
Keywords:
acute infectious rhinitis, silver proteinate. For citation:
Kiselev A. B., Abdulkerimov Kh. T., Terskova N. E., Chaukina V. A. Clinical efficacy of the drug 200 mg silver proteinate in the complex therapy of acute infectious rhinitis in children, which occurred as part of an acute respiratory infection. Rossiiskaya otorinolaringologiya. 2021;20(4):88-95. https://doi.org/10.18692/1810-4800-2021-4-88-95